ENBC will be discussed by Joe K. in next segment. . .1.4 mil float. . already traded float. . .extremely volatile. . . should be fun for those that love excitement.
Here is news he will discuss:
Energy BioSystems Corporation Demonstrates
Proprietary Gene Shuffling Technology
Business Wire - February 07, 2000 08:19
THE WOODLANDS, Texas--(BW HealthWire)--Feb. 7, 2000--Energy BioSystems
Corporation (Nasdaq:ENBC) announced today that it has completed the
demonstration of a new, proprietary gene shuffling technology. Gene shuffling is a
powerful method to create millions of new variant genes coding for enzymes with
improved properties. The company has successfully applied the technology to its
biodesulfurization development efforts and is now exploring opportunities for the
technology in areas beyond biorefining including the chemical, pharmaceutical and
agricultural biotechnology sectors.
"Difficulties with existing methods to generate genetic diversity prompted us to
develop our own technologies," noted Dr. Daniel J. Monticello, vice president of
research and development at ENBC. "We've successfully used this new gene
shuffling technique in our directed evolution program to combine the best properties
of related desulfurization enzymes and generate superior strains. Our approach has
important advantages over known technologies and has accelerated our development
program." Dr. Monticello will be disclosing certain details of the technology and its
implications to ENBC's projects at the IBC "Annual World Congress on Enzyme
Technologies 2000" in February ( ibcusa.com ).
Dr. Peter Policastro, CEO and president of ENBC, indicated that the technology
was part of a comprehensive effort to expand the Company's capabilities. "In 1999,
we implemented a strategic initiative to capitalize on our unique genetic capabilities.
The demonstration of our proprietary gene shuffling technology creates both new
and complementary business opportunities. Our gene shuffling technology has
already made a significant impact on our biodesulfurization program. We intend to
apply these capabilities to other projects in the ENBC pipeline and to other
opportunities as we identify them."
Energy BioSystems Corporation is a biotechnology company applying state-of-the
art, proprietary directed evolution techniques to accelerate the development and
commercialization of biocatalyst-based processes for petroleum refining,
petrochemicals and fine chemicals production. The Company's primary focus has
been development of biocatalytic desulfurization (BDS), a proprietary process
involving the use of enzymes to remove sulfur from oil. Additional information about
Energy BioSystems is available at the company's web site:
energybiosystems.com.
This document contains forward-looking statements that are subject to certain risks,
uncertainties and assumptions, including but not limited to, the company's ability to
raise additional capital on a timely basis on favorable terms, the development of the
company's proprietary technology, government regulations, competitive technologies,
and the company's ability to control expenditures. Should one or more of such risks
and uncertainties materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated in such forward-looking
statements. For a discussion of such risks and assumptions, see "Risk Factors"
included in the company's annual report on Form 10-K for the year ended Dec. 31,
1998.
CONTACT: Energy BioSystems Corporation, The Woodlands
Paul G. Brown III, 281/364-6140 |
